Abstract
Jingyuan Gao, Xinzhu Yi, Zhang Wang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The lung microbiome in health and disease
10.7861/clinmedicine.17-6-525 · 2017
The human lung microbiome—a hidden link between microbes and human health and diseases
2022
The lung microbiome: progress and promise
10.1172/jci150473 · 2021
10.1586/ers.13.24
10.1586/ers.13.24
Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4
10.1038/s41587-023-01688-w · 2023
A multi-omic future for microbiome studies
10.1038/nmicrobiol.2016.49 · 2016
10.1016/j.csbj.2021.11.029
10.1016/j.csbj.2021.11.029
Radiomics in lung diseases imaging: state-of-the-art for clinicians
2021
Sputum induction
2002
Microbiome characteristics of induced sputum compared to bronchial fluid and upper airway samples
10.1002/ppul.24037 · 2018
10.1164/rccm.201104-0655oc
10.1164/rccm.201104-0655oc
Full-length 16S rRNA gene amplicon analysis of human gut microbiota using MinION nanopore sequencing confers species-level resolution
10.1186/s12866-021-02094-5 · 2021
A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels
10.3389/fmicb.2020.01758 · 2020
Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study
10.1183/13993003.00766-2018 · 2018
10.1038/nbt.3935
10.1038/nbt.3935
Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles
10.1016/j.celrep.2019.01.091 · 2019
10.1186/s40168-018-0426-3
10.1186/s40168-018-0426-3
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection
10.1038/s41587-019-0156-5 · 2019
Advances and challenges in metatranscriptomic analysis
10.3389/fgene.2019.00904 · 2019
Transcriptionally active lung microbiome and its association with bacterial biomass and host inflammatory status
2018
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
10.1183/13993003.03434-2020 · 2021
Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome
2021
Lower airway dysbiosis augments lung inflammatory injury in mild-to-moderate COPD
10.1164/rccm.202210-1865oc · 2023
Metaproteomics: much more than measuring gene expression in microbial communities
10.1128/msystems.00115-19 · 2019
10.1007/s00248-006-9196-8
10.1007/s00248-006-9196-8
10.1016/j.jbiotec.2017.06.1201
10.1016/j.jbiotec.2017.06.1201
Pregnancy zone protein is associated with airway infection, neutrophil extracellular trap formation, and disease severity in bronchiectasis
10.1164/rccm.201812-2351oc · 2019
Airway host-microbiome interactions in chronic obstructive pulmonary disease
10.1186/s12931-019-1085-z · 2019
Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions
10.1038/s41564-022-01196-8 · 2022
A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes
2022
The sputum microbiome, airway inflammation and mortality in chronic obstructive pulmonary disease
2020
10.1016/s2213-2600(20)30504-x
10.1016/s2213-2600(20)30504-x
Sputum proteomics in nontuberculous mycobacterial lung disease
10.1016/j.chest.2021.11.014 · 2022
Understanding the host-microbe interactions using metabolic modeling
10.1186/s40168-020-00955-1 · 2021
Neisseria species as pathobionts in bronchiectasis
2022
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease
10.1016/j.chom.2023.04.018 · 2023
AMON: annotation of metabolite origins via networks to integrate microbiome and metabolome data
10.1186/s12859-019-3176-8 · 2019
10.1002/imt2.10
10.1002/imt2.10
10.1016/j.ccm.2016.11.001
10.1016/j.ccm.2016.11.001
Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children
10.1038/s41467-019-10294-x · 2019
10.1038/s41396-020-0727-y
10.1038/s41396-020-0727-y · doi-reference
10.1016/j.jaci.2016.08.055
10.1016/j.jaci.2016.08.055 · doi-reference
Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD
10.1016/j.phrs.2020.105095 · doi-reference
Integrate multi-omics data with biological interaction networks using Multi-view Factorization AutoEncoder (MAE
10.1186/s12864-019-6285-x · doi-reference
10.1038/s41587-022-01520-x
10.1038/s41587-022-01520-x · doi-reference
MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification
10.1038/s41467-021-23774-w · doi-reference
10.18637/jss.v028.i05
10.18637/jss.v028.i05 · doi-reference
10.1371/journal.pcbi.1002687
10.1371/journal.pcbi.1002687 · doi-reference
10.1371/journal.pcbi.1004226
10.1371/journal.pcbi.1004226 · doi-reference
10.12688/f1000research.9050.1
10.12688/f1000research.9050.1 · doi-reference
10.1371/journal.pcbi.1009442
10.1371/journal.pcbi.1009442 · doi-reference
Differential proteomic patterns of plasma extracellular vesicles show potential to discriminate β-thalassemia subtypes
10.1016/j.isci.2023.106048 · doi-reference
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma
10.1183/13993003.02298-2016 · doi-reference
Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma
10.3389/fgene.2022.1064432 · doi-reference
Single sample pathway analysis in metabolomics: performance evaluation and application
10.1186/s12859-022-05005-1 · doi-reference
10.1186/s40168-018-0541-1
10.1186/s40168-018-0541-1 · doi-reference
The lung microbiota affects pulmonary inflammation and oxidative stress induced by pm(2.5) exposure
10.1021/acs.est.1c08888 · doi-reference
10.1038/s41586-022-04427-4
10.1038/s41586-022-04427-4 · doi-reference
10.1158/2159-8290.cd-20-0263
10.1158/2159-8290.cd-20-0263 · doi-reference
Interaction between the microbiome and TP53 in human lung cancer
10.1186/s13059-018-1501-6 · doi-reference
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study
10.1001/jamaoncol.2019.2996 · doi-reference
10.1038/s41579-022-00821-x
10.1038/s41579-022-00821-x · doi-reference
Multi-omics profiling predicts allograft function after lung transplantation
10.1183/13993003.03292-2020 · doi-reference
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation
10.1038/s41467-021-22344-4 · doi-reference
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
10.1038/s41467-021-26500-8 · doi-reference
Dynamics of the upper respiratory tract microbiota and its association with mortality in COVID-19
10.1164/rccm.202103-0814oc · doi-reference
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients
10.1038/s41421-021-00257-2 · doi-reference
10.1056/nejmoa2002032
10.1056/nejmoa2002032 · doi-reference
Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis
10.1164/rccm.201809-1650oc · doi-reference
10.1164/rccm.201607-1525oc
10.1164/rccm.201607-1525oc · doi-reference
10.1164/rccm.201607-1408oc
10.1164/rccm.201607-1408oc · doi-reference
10.1164/rccm.202205-0893oc
10.1164/rccm.202205-0893oc · doi-reference
10.1016/s0140-6736(18)31767-7
10.1016/s0140-6736(18)31767-7 · doi-reference
Bronchiectasis
10.1038/s41572-018-0042-3 · doi-reference
Lung microbiota and metabolites collectively associate with clinical outcomes in milder stage chronic obstructive pulmonary disease
10.1164/rccm.202110-2241oc · doi-reference
10.1164/rccm.201504-0779oc
10.1164/rccm.201504-0779oc · doi-reference
10.1164/rccm.202009-3448oc
10.1164/rccm.202009-3448oc · doi-reference
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
10.1136/thoraxjnl-2017-210741 · doi-reference
10.1183/13993003.01406-2015
10.1183/13993003.01406-2015 · doi-reference
Chronic obstructive pulmonary emphysema; a disease of smokers
10.7326/0003-4819-45-2-268 · doi-reference